Weight Loss After Receiving Anti-Obesity Medications and Gout Among Individuals With Overweight and Obese: A Population-Based Cohort Study

被引：2

作者：

Wei, Jie ^{[1
,2
]}

Wang, Yilun ^{[3
,4
]}

Dalbeth, Nicola ^{[5
]}

Xie, Junqing ^{[6
]}

Wu, Jing ^{[4
,7
]}

Zeng, Chao ^{[1
,8
]}

Lei, Guanghua ^{[1
,8
]}

Zhang, Yuqing ^{[9
]}

机构：

[1] Cent South Univ, Xiangya Hosp, Hunan Key Lab Joint Degenerat & Injury, Key Lab Aging Related Bone & Joint Dis Prevent & T, Changsha, Peoples R China

[2] Cent South Univ, Xiangya Sch Publ Hlth, Changsha, Peoples R China

[3] Cent South Univ, Xiangya Hosp, Hunan Key Lab Joint Degenerat & Injury, Changsha, Peoples R China

[4] Cent South Univ, Xiangya Hosp, Key Lab Aging Related Bone & Joint Dis Prevent & T, Minist Educ, Changsha, Peoples R China

[5] Univ Auckland, Auckland, New Zealand

[6] Univ Oxford, Oxford, England

[7] Cent South Univ, Xiangya Hosp, Hunan Key Lab Joint Degenerat & Injury, Minist Educ, Changsha, Peoples R China

[8] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China

[9] Harvard Med Sch, Massachusetts Gen Hosp, Mongan Inst, Boston, MA 02115 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2024年

关键词：

RISK-FACTOR INTERVENTION; SERUM URATE; BARIATRIC SURGERY; ORLISTAT; HYPERURICEMIA; ASSOCIATION; PEOPLE; IMPACT; MEN;

D O I：

10.1002/art.42996

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

ObjectiveWeight loss is conditionally recommended for gout management; however, its impact on incident gout and recurrent gout flares among individuals who were overweight and obese remains unknown. We investigate the relationship between weight loss rate following treatment with anti-obesity medications and the risk of incident gout and recurrent gout flares among individuals who were overweight or obese.MethodsUsing data from the Health Improvement Network, we selected individuals aged 18 and older who were overweight or obese and started anti-obesity medication. We emulated a target trial to examine the association of different weight loss rates, slow (2%-5%), moderate (5%-10%), or fast (>= 10%), within the first year of treatment with incident gout and recurrent gout flares during a 5 year follow-up period.ResultsAmong 131,000 participants without gout being treated with orlistat, the 5-year risk of incident gout was 1.6% for those with weight gain or stability, compared with 1.5%, 1.3%, and 1.2% for those with slow, moderate, and fast weight loss, respectively. Compared with the group with weight gain or stability, the hazard ratios were 0.91 (95% confidence interval [CI] 0.81-1.01), 0.82 (95% CI 0.72-0.92), and 0.73 (95% CI 0.62-0.86) for those with a slow, moderate, and fast rate of weight loss, respectively. Similar results were observed for the recurrent gout flares among 3,847 individuals with overweight or obese with gout treated with orlistat.ConclusionA higher rate of weight loss after receiving treatment with orlistat within 1 year was associated with lower risks of incident gout and lower rates of recurrent gout flares among overweight or obese people. imageConclusionA higher rate of weight loss after receiving treatment with orlistat within 1 year was associated with lower risks of incident gout and lower rates of recurrent gout flares among overweight or obese people. image

引用

页码：335 / 345

页数：11

共 36 条

[1] THE MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT) .3. THE MODEL FOR INTERVENTION [J].

BENFARI, RC .

PREVENTIVE MEDICINE, 1981, 10 (04) :426-442

[2] Effect of orlistat on weight and body composition in obese adolescents - A randomized controlled trial [J].

Chanoine, JP ;

Hampl, S ;

Jensen, C ;

Boldrin, M ;

Hauptman, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (23) :2873-2883

[3] Manifestations of metabolic syndrome associated with male gout in different age strata [J].

Chen, Shih-Yang ;

Chen, Ching-Lang ;

Shen, Ming-Lai .

CLINICAL RHEUMATOLOGY, 2007, 26 (09) :1453-1457

[4] Obesity, weight change, hypertension, diuretic use, and risk of gout in men - The health professionals follow-up study [J].

Choi, HK ;

Atkinson, K ;

Karlson, EW ;

Curhan, G .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (07) :742-748

[5] Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial [J].

Christensen, Robin ;

Zobbe, Kristian ;

Nielsen, Sabrina M. ;

Stamp, Lisa K. ;

Henriksen, Marius ;

Overgaard, Anders F. ;

Dreyer, Lene ;

Knop, Filip K. ;

Singh, Jasvinder A. ;

Doherty, Michael ;

Richette, Pascal ;

Astrup, Arne ;

Ellegaard, Karen ;

Bartels, Else M. ;

Boesen, Mikael ;

Gudbergsen, Henrik ;

Bliddal, Henning ;

Kristensen, Lars Erik .

ARTHRITIS & RHEUMATOLOGY, 2024, 76 (05) :806-812

[6] Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout [J].

Cipolletta, Edoardo ;

Tata, Laila J. ;

Nakafero, Georgina ;

Avery, Anthony J. ;

Mamas, Mamas A. ;

Abhishek, Abhishek .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (05) :440-450

[7] Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study [J].

Dalbeth, Nicola ;

Chen, Peggy ;

White, Marie ;

Gamble, Gregory D. ;

Barratt-Boyes, Caran ;

Gow, Peter J. ;

Orr-Walker, Brandon .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (05) :797-802

[8] Role of diet in hyperuricemia and gout [J].

Danve, Abhijeet ;

Sehra, Shiv Tej ;

Neogi, Tuhina .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2021, 35 (04)

[9] Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors [J].

Dehlin, Mats ;

Jacobsson, Lennart ;

Roddy, Edward .

NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (07) :380-390

[10] Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study [J].

Dessein, PH ;

Shipton, EA ;

Stanwix, AE ;

Joffe, BI ;

Ramokgadi, J .

ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (07) :539-543

← 1 2 3 4 →